Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Orthop Res. 2019 Sep 6;38(1):139–149. doi: 10.1002/jor.24451

Figure 3.

Figure 3.

To investigate how long DEX treatment was required to mitigate secondary tendon damage, BTM explants were incubated with DEX for the first 1, 2, 3, or 7 days in the culture period (n=7–10/group/timepoint). (B) One day of DEX treatment significantly reduced viability at day 3 but was improved by day 7 compared to (A) control BTM. (C) Two and (D) three days of treatment improved viability only at day 5 compared to controls. Data are presented as mean ± 95% confidence interval where significant differences compared to the BTM control group are represented by stars (*).